I think Antibotter is right.
If we read between the lines, Jackie announces her retirement in 2024, then remains as a consultant to her replacement for 12 months.....so will be with us until the end of 2025 probably.
In between we're expecting the results of the UK Viraleze as a treatment trial plus Phase 2 DEP results before the end of 2023.....so the development phase of SPL's business will be complete.....that was Jackie's job
Then we can expect a new CEO, probably a commercial CEO, to take the helm
Previously only a scientific CEO had the knowledge to take the helm.
Read between lines, good times ahead!
Ann: Starpharma CEO to retire in 2024, page-44
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.7¢ |
Change
-0.001(1.02%) |
Mkt cap ! $40.48M | |||
| Open | High | Low | Value | Volume |
| 9.6¢ | 10.0¢ | 9.6¢ | $5.703K | 58.16K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 9.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.8¢ | 20000 | 1 |
View Market Depth
| Last trade - 15.41pm 11/10/2024 (20 minute delay) ? |
| SPL (ASX) Chart |